Going Global
International expansion for 270 Vision 270 Vision has announced ambitious expansion plans, as the med-tech business seeks to raise investment to support its growth and the deployment of two new products.
T
he Hampshire-based company has gone from strength to strength with BPMpathway, which offers cost-effective and reliable technology in support of remote patient assessment undertaken by clinicians. They now aim to utilise the technology to diversify into new markets in an investment raise through the Elevate investment network.
Founded in 2011, 270 Vision are developers of simple-to-use, highly accurate body analysis technology for use in injury prevention and rehabilitation in the medical, employee welfare and elite sports sectors. With six patents granted and two further applications pending, multi-award winning 270 Vision are internationally renowned as the market leaders in motion sensor design and development.
In 2016, recognising the potential of BPMpathway, international healthcare giants B. Braun first invested into 270 Vision as part of their strategy of securing access to key future technology and to take the product into patient rehabilitation post orthopaedic surgery under a global distribution agreement. In 2018, B. Braun further increased their stake in the company to support the worldwide rollout of BPMpathway which, through the partnership, has gone on to be certified in 14 countries. Of those 14 countries, it has already been successfully launched into seven, including China and India, and it is expected to be launched into Japan and South Korea later in 2021.
BresMed’s new global HQ at Steel City House in Sheffield is the heart of the company’s worldwide operation. Commenting on the move, CEO Nic Brereton said: “I am so proud to be expanding BresMed tobeen thesefantastic, premium “Our journey to date has premises in the city. The building very and we have been extremely proudmuch to fitshave with been our brand – it’s iconic a quirky recognised with awith National feelMedilink and, likeOutstanding us, it dares toAchievement be different.”
Award, as well as securing the The company has come a long way since Nic partnership with B. Braun, without moved into a one-person office in the city whom the scale of the expansion to date many years ago, adding: “Actually, it was more would not have been possible.” a cupboard! However, it helped me launch the Martin Gossling business.” CEO and Co-founder 270 Vision
In addition to the Medilink Award, the business has won several further accolades, including the Best Digital Health Platform award for BPMpathway at the 2018 Juniper Research Future Digital Awards. Having successfully raised £2.9m in investment to date, the business is now seeking to raise further investment through the Elevate investment network, to aid their growth plans and support the launch of new products including WPMpro and BPMcare. Commenting on the new products, CFO and Co-founder Jane Gossling said: “WPMpro is a cost-effective system at the forefront of the next generation of wearable sensor technology. Multiple smart, autonomous sensors detect excessive joint range
of motion to help employers identify individuals at risk of injury and, through pro-active early intervention, limit the cost and disruption caused by work-related musculoskeletal disorders.” Jane added: “WPMpro technology is a game-changer in the world of wearables. For the first time, far field charging of the multiple sensors can be delivered in a production solution. There is currently no commercially available solution capable of producing a complete body assessment, because manually charging even two-three sensors has been deemed impractical. With WPMpro, however, as many as 20 sensors can be distributed throughout a person’s clothing without the wearer being aware of them. These sensors are then charged overnight as they hang in the individual’s locker using patent-pending RF transmitters at regulated frequencies developed by 270 Vision.” In addition to smart clothing, 270 Vision is also looking to develop its BPMcare technology. Jane explained: “BPMcare uses technology complementary to BPMpathway in the remote monitoring of bio-signs and urinary issues in patients in long term care, particularly those with comorbidities and catheter users. BPMcare technology is designed to detect blood and dehydration to help reduce the risk of infection and further complications”.
www.bpmpathway.com
30
Issue 20
